Risk is proportional to reward.
The almost guaranteed FDA approval of Sofdra, given the minor packaging amendments required, makes me wonder how much approval has already been priced into the announcement?
Makes me think of CYC and the sell down almost as soon as FDA approval. Not saying the same thing will happen with BOT.
Definitely been a hard slog for long termers. Those who’ve held really deserve an good outcome!
BOT - Anything but charting, page-8830
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1234 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 119 | 1 |
View Market Depth
| Last trade - 09.43am 01/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
Day chart unavailable